The Chinese natural product, berberine, has biological properties that support its potential efficacy as a colon cancer prevention agent. Its longstanding use in China to treat gastrointestinal tract and rheumatologic disorders is generally regarded as safe, supporting initial investigations in an at-risk population, such as individuals with ulcerative colitis. However, the safety of berberine in this population is not established. Individuals living in China with biopsy-proven ulcerative colitis, grade 2 dysplasia, and with a ulcerative colitis disease activity index (UCDAI) score 1 on mesalamine, were randomized 3:1 in a double-blind phase I trial to berberine 900 mg/day or placebo for 3 months, with the primary objective of assessing safety. Blood samples and biopsies of the colorectum, from prespecified locations, were collected prior to and following therapy. Secondary end-points included changes in UCDAI score, and in tissue and plasma markers of inflammation. Of toxicities at least possibly related, one episode of grade 3 elevation in transaminases and one episode of grade 1 nausea were observed among 12 individuals on berberine, and none were observed among 4 on placebo. The mean plasma berberine concentration was 3.5 nmol/L after berberine treatment, significantly higher than 0.5 nmol/L with placebo. Berberine significantly decreased the Geboes grade in colonic tissue, but had a nonsignificant effect on other tissue or blood biomarkers related to cell growth and inflammation. The combination of berberine and mesalamine is well tolerated in Chinese with ulcerative colitis and may enhance mesalamine's anti-inflammatory effects in colonic tissue.

Leaf size (i.e., leaf surface area and leaf dry mass) profoundly affects a variety of biological carbon, water and energy processes. Therefore, the remarkable variability in individual leaf size and its trade-off with total leaf number in a plant have particularly important implications for understanding the adaption strategy of plants to environmental changes. The various leaf sizes of plants growing in the same habitat are expected to have distinct abilities of thermal regulation influencing leaf water loss and shedding heat. Here, we sampled 16 tree species co-occurring in a temperate forest in northeastern China to quantify the variation of leaf, stomata and twigs traits, and to determine the relationships of leaf size with leaf number and leaf water loss. We examined the right-skewed distributions of leaf size, leafing intensity, stomatal size and stomatal density across species. Leafing intensity was significantly negatively correlated with leaf size, accounting for 4 and 12% of variation in leaf area and leaf mass, respectively. Species was the most important factor in explaining the variation in leaf size (conditional R2 of 0.92 for leaf area and 0.82 for leaf mass). Leaf area and mass significantly increased with increasing diameter of twigs. Leaf water loss was strongly negatively correlated with leaf area and leaf mass during the first four hours of the measurement. Leaf area and leaf mass accounted for 38 and 30% of variation in total leaf water loss, respectively. Leaf water loss rate (k) was significantly different among tree species and markedly linearly decreased with increasing leaf area and leaf mass for simple-leaved tree species. In conclusion, the existence of a cross-species trade-off between the size of individual leaves and the number of leaves per yearly twig unit was confirmed in that temperate forest. There was strongly negative correlation between leaf water loss and leaf size across tree species, which provides evidences for leaf size in leaf temperature regulation in dry environment with strong radiation. The size-dependent leaf water relation is of central importance to recognize the functional role of leaf size in a changing climate including rapid changes in air temperature and rainfall.

Objectives. Laser therapy is a promising new treatment for patients with recurrent aphthous stomatitis (RAS). However, the clinical effect and security issue of laser therapy remain controversial. This systematic review was conducted to evaluate the clinical effectiveness and security of laser treatment in RAS patients. Methods. Five electronic databases were searched (MEDLINE (PubMed), EMBASE, ScienceDirect, the Cochrane Library, and Web of Science) to identify all studies that were about randomized controlled clinical trials, involving the effect of laser therapy in RAS patients. Conclusion. Twenty-three studies were retained for full-text analysis after screening the titles and abstracts of potential articles, but only 10 studies satisfied the inclusion criteria after the full texts were reviewed. The included studies reported a comparison of the effectiveness between the laser treatment and placebo laser therapy (or conventional drug therapy) when managing the RAS patients. It can be concluded that laser therapy has the superiority in relieving ulcer pain and shortening healing time when compared with placebo group or medical treatment group. Although laser therapy is a promising effective treatment for RAS, high-quality clinical studies with large sample size must be further performed to confirm the effectiveness of this therapy.

Although haemodynamic and electrolyte changes remains stable, a trend towards metabolic acidosis is obvious as the irrigation time goes by during MPCNL compared with PCNL. Therefore, arterial blood gases should be monitored during and after MPCNL in patients with prolonged irrigation time.